tiprankstipranks
Trending News
More News >
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Financial Statements

Compare
348 Followers

Evaxion Biotech Financial Overview

Evaxion Biotech's market cap is currently $3.35M. The company's EPS TTM is $-0.01; its P/E ratio is ―; Evaxion Biotech is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 3.34M$ 73.00K$ 0.00$ 0.00$ 0.00
Gross Profit$ 3.34M$ 72.89K$ -571.32K$ -343.45K$ -105.72K
Operating Income$ -14.73M$ -22.20M$ -25.26M$ -25.83M$ -16.57M
EBITDA$ -9.77M$ -21.40M$ -22.58M$ -24.17M$ -16.46M
Net Income$ -10.57M$ -22.13M$ -23.17M$ -24.53M$ -15.02M
Balance Sheet
Cash & Short-Term Investments$ 5.05M$ 5.58M$ 13.18M$ 32.17M$ 5.83M
Total Assets$ 12.48M$ 12.89M$ -58.94M$ 40.16M$ 11.96M
Total Debt$ 10.10M$ 10.87M$ 2.25M$ 3.69M$ 20.00K
Net Debt$ 5.05M$ 5.29M$ -10.93M$ -28.48M$ -5.81M
Total Liabilities$ 14.14M$ 17.62M$ 13.72M$ 7.73M$ 4.93M
Stockholders' Equity$ -1.65M$ -4.73M$ -72.66M$ -50.43M$ 7.04M
Cash Flow
Free Cash Flow$ -12.94M$ -17.78M$ -26.07M$ -23.29M$ -12.83M
Operating Cash Flow$ -12.94M$ -17.69M$ -25.77M$ -21.93M$ -12.44M
Investing Cash Flow$ -3.00K$ -93.00K$ -268.00K$ -1.33M$ -393.00K
Financing Cash Flow$ 13.13M$ 10.69M$ 7.85M$ 49.80M$ 8.82M
Currency in USD

Evaxion Biotech Earnings and Revenue History

Evaxion Biotech Debt to Assets

Evaxion Biotech Cash Flow

Evaxion Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis